Differentiation of human iPSCs into VSMCs and generation of VSMC-derived calcifying vascular cells

The presented method could help to study genetic risk variants, using the CRISPR/Cas technology through the introduction of Knockouts or Knockins of risk variants. Finally, this method can be applied for drug screening.